Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Needlestick Remove


June 2015
Tu Mo Su Sa Fr Th We
30 29 28 27 26 25 24

needlestick Press Releases

  + XML/RSS  



By MediPurpose Inc.
Reinforces MediPurpose’s Commitment to Supporting Australian Sharps Safety
By MediPurpose Inc.
Bolsters Support for MediPurpose’s Expanding Medical Device Distribution in EMEA
By MediPurpose Inc.
Internationally Expands Neonatal Medical Device’s Intellectual Property Protection
By MediPurpose Inc.
Reorganization Ensures Continued Focus on Customer Satisfaction and Communication While Keeping Company Lean, Efficient
By MediPurpose Inc.
New White Paper Demonstrates Single-Use Fingerstick Device’s Adherence to Safe in Common’s Guidelines for Sharps Safety
By MediPurpose Inc.
MediPurpose™, a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of lancet patents.
By MediPurpose Inc.
MediPurpose(tm), a master distributor and manufacturer of medical products, today announced the publication of its annual Chairman's Letter to Shareholders for fiscal year 2013.
By MediPurpose Inc.
POC Diagnostics Manufacturer to Use SurgiLance™ Safety Lancets in Blood Analysis Equipment
By MediPurpose™
Follows and Validates Recent Grant of European Patent Office (EPO) Patent 2303123
By MediPurpose™
Representatives Onsite to Demonstrate babyLance™ Safety Heelstick Device
By MediPurpose™
New White Paper Examines Neonatal Heelstick’s Adherence to Safe in Common’ Rules for Sharps Safety
By MediPurpose™
Expands MediPurpose’s Lancet Intellectual Property Portfolio
By MediPurpose™
Examines babyLance Safety Heelstick’s Activation, Ease of Use, Incision Quality and Safety
By MediPurpose™
Introduced in 1999 as the SurgiLance One-Step safety lancet, MediPurpose’s flagship medical product has sold steadily since its launch.
By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application
By Sandwell and West Birmingham Hospitals NHS Trust
The trust which runs hospital services in Sandwell and west Birmingham is aiming to reduce infection rates, enhance patient recovery and improve safety by standardising their needle-free devices with a single, innovative product.
By MediPurpose™
Reflects U.S. FDA 510(k) Clearance for Marketing Neonatal Heelstick Device with a Sharps Prevention...
By MediPurpose™
Examines Additional Considerations for Sharps Prevention Features and Submissions for a Modified Medical Device with Existing 510(k)...
By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada
By MediPurpose™
Only Infant Heelstick to Have FDA 510(k) Clearance for Sharps Prevention Indication

All Press Releases

By MediPurpose Inc.
Continues Tradition of Exciting Prize Drawings and Engagement with Neonatal Nursing Attendees at babyLance(tm) Safety Heelstick Exhibitor Booth
By MediPurpose Inc.
Reinforces MediPurpose’s Commitment to Supporting Australian Sharps Safety
By MediPurpose Inc.
Bolsters Support for MediPurpose’s Expanding Medical Device Distribution in EMEA
By MediPurpose Inc.
Internationally Expands Neonatal Medical Device’s Intellectual Property Protection
By MediPurpose Inc.
Reorganization Ensures Continued Focus on Customer Satisfaction and Communication While Keeping Company Lean, Efficient
By MediPurpose Inc.
New White Paper Demonstrates Single-Use Fingerstick Device’s Adherence to Safe in Common’s Guidelines for Sharps Safety
By MediPurpose Inc.
MediPurpose™, a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of lancet patents.
By MediPurpose Inc.
MediPurpose(tm), a master distributor and manufacturer of medical products, today announced the publication of its annual Chairman's Letter to Shareholders for fiscal year 2013.
By MediPurpose Inc.
POC Diagnostics Manufacturer to Use SurgiLance™ Safety Lancets in Blood Analysis Equipment
By MediPurpose Inc.
Representatives Available to Discuss Medical Product Distribution Opportunities for Safety Blood Collection Devices
By MediPurpose™
Follows and Validates Recent Grant of European Patent Office (EPO) Patent 2303123
By MediPurpose™
Representatives Onsite to Demonstrate babyLance™ Safety Heelstick Device
By MediPurpose™
New White Paper Examines Neonatal Heelstick’s Adherence to Safe in Common’ Rules for Sharps Safety
By MediPurpose™
Expands MediPurpose’s Lancet Intellectual Property Portfolio
By MediPurpose™
Examines babyLance Safety Heelstick’s Activation, Ease of Use, Incision Quality and Safety
By MediPurpose™
Introduced in 1999 as the SurgiLance One-Step safety lancet, MediPurpose’s flagship medical product has sold steadily since its launch.
By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application
By Sandwell and West Birmingham Hospitals NHS Trust
The trust which runs hospital services in Sandwell and west Birmingham is aiming to reduce infection rates, enhance patient recovery and improve safety by standardising their needle-free devices with a single, innovative product.
By MediPurpose™
Reflects U.S. FDA 510(k) Clearance for Marketing Neonatal Heelstick Device with a Sharps Prevention...
By MediPurpose™
Examines Additional Considerations for Sharps Prevention Features and Submissions for a Modified Medical Device with Existing 510(k)...
By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada
By MediPurpose™
Only Infant Heelstick to Have FDA 510(k) Clearance for Sharps Prevention Indication
By MediPurpose Pte.
Recertification Validates MediPurpose’s Medical Product Quality Management System (QMS)
By MediPurpose™
Results From Simulated and Clinical Use Survey at Citrus Valley Medical Center
By MediPurpose™
Company's Safety Medical Devices Designed to Prevent Accidental Needlestick Injuries
By MediPurpose™
1900 cases of babyLance(tm) infant heelsticks donated to international humanitarian aid and disaster relief organization
By MediPurpose™
babyLance Heelstick Reinvention Process Prioritized Harmony Between End-User Ergonomic Requirements and Design Team Innovation
By MediPurpose Inc.
Safety Lancet Complaint Rate Less Than One in Five Million in 2012
By Asante Health System
Rogue Valley Medical Center is using the VeinViewer Vision device for vascular imaging. It projects the location of a patient’s veins directly on the surface of the skin, providing a safe road map when inserting a needle into a vein.


Page:
  • 1

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share